Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Vial will be at CNS 2022 Annual Meeting

October 9-12, 2022 | San Francisco, CA

Vial is proud to attend the 2022 Congress of Neurological Surgeons Annual Meeting.

Meet with us

Let us know if you’d like to connect with us before or at the event by submitting the form below.

Vial staff attending the event:

Andrew Brackin
Andrew Brackin
Co-founder & Chief Revenue Officer
John Sheperdson
Strategic Growth Executive

Meet with us!

Name(Required)
By submitting, you are agreeing to our terms and privacy policy